Wall Street brokers expect Tandem Diabetes Care, Inc. (NASDAQ: TNDM) to generate revenue of $ 114.67 million in the current fiscal quarter, according to...
Late breaking poster presentation with full 12-month follow-up results and 6-month crossover patient data for SENZA-PDN randomized controlled trialCompany to hold investor briefing on...